Sotagliflozin loss of exclusivity date?

When does sotagliflozin lose exclusivity?

I don’t have enough information in the provided materials to state a specific “loss of exclusivity” (LOE) date for sotagliflozin. LOE depends on the country/market and on the specific regulatory exclusivities involved (for example, patent expirations versus data/exclusivity protections tied to first authorization).

If you tell me the market (e.g., US, EU/UK, Canada, Japan) and the brand name/source reference you mean (e.g., In general searches people may refer to branded products), I can give a precise LOE date using the relevant exclusivity type(s).

Is LOE the same as patent expiry?

Not always. LOE for an active ingredient can reflect more than one protection layer:
- Composition of matter patent expiry (often the biggest driver)
- Additional/secondary patents (formulations, methods, combinations)
- Regulatory data exclusivity and market exclusivity rules (can extend beyond the first patent date, depending on jurisdiction)

So “loss of exclusivity date” in a drug-forecast context may differ from the first patent expiration date.

What affects the LOE date for sotagliflozin?

Key drivers are jurisdiction and which exclusivity the forecast is tracking:
- The first approved indication (authorization timing matters for exclusivity start)
- Whether extensions apply (for example, pediatric or other regulatory extensions, where permitted)
- Whether there are later patents covering new formulations, dosing, or combinations
- Whether biosimilars are relevant (for small-molecule like sotagliflozin, typical “biosimilar” concepts usually do not apply; instead it’s generics and/or other small-molecule exclusivity regimes)

What should I check to find the exact LOE date?

To get an exact LOE date, you typically need:
- The country (LOE rules are not global)
- The specific product/marketing authorization (not just the molecule)
- The relevant exclusivity category used in the source you’re consulting (patent expiry vs data exclusivity vs marketing exclusivity)

Quick clarifying question

Which jurisdiction and reference do you need the sotagliflozin LOE date for (US, EU/UK, or another country)? If you share that, I’ll provide the specific date.